Skip Nav Destination

Online First / Early View

Online First
Early View

Online first articles are accepted and edited, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI.

Online First

Other Types November 30 2023

PharmaNews

Breast Care (2023) https://doi.org/10.1159/000535436

View articletitled, PharmaNews

Open the PDF for in another window

Other Types November 27 2023

Acknowledgement to Reviewers

Breast Care (2023) https://doi.org/10.1159/000535217

View articletitled, Acknowledgement to Reviewers

Open the PDF for in another window

Research Articles November 9 2023

The Factors Influencing Shoulder Mobility Disorders in Patients after Radical Breast Cancer Surgery: A Cross-Sectional Study

Xin Zhang; Chao Wang; Jialin Fan; Shinichiro Murakami; Hualong Xie; Ming Huo

Breast Care (2023) https://doi.org/10.1159/000535063

Abstract

View articletitled, The Factors Influencing Shoulder Mobility Disorders in Patients after Radical Breast Cancer Surgery: A Cross-Sectional Study

Open the PDF for in another window

Corrections/Errata November 6 2023

Erratum - Clinicopathologic Features and Pathogens of Granulomatous Lobular Mastitis

Breast Care (2023) https://doi.org/10.1159/000534246

View articletitled, Erratum - Clinicopathologic Features and Pathogens of Granulomatous Lobular Mastitis

Open the PDF for in another window

Review Articles October 25 2023

HER2+ Early Breast Cancer: From Escalation via Targeted and Post-Neoadjuvant Treatment to De-Escalation

Monika Graeser; Oleg Gluz

Breast Care (2023) https://doi.org/10.1159/000534670

Abstract

View articletitled, HER2+ Early Breast Cancer: From Escalation via Targeted and Post-Neoadjuvant Treatment to De-Escalation

Open the PDF for in another window

Research Articles October 17 2023

Use of the Gene Expression Test Prosigna^® in Premenopausal Patients with HR+, HER2− Early Breast Cancer: Correlation of the Results with the Proliferation Marker Ki-67

Cordula Ziegler; Karl Sotlar; Daniel Maria Hofmann; Thomas Kolben; Nadia Harbeck; Rachel Würstlein

Breast Care (2023) https://doi.org/10.1159/000534634

Abstract

View articletitled, Use of the Gene Expression Test Prosigna<sup>®</sup> in Premenopausal Patients with HR+, HER2− Early Breast Cancer: Correlation of the Results with the Proliferation Marker Ki-67

Open the PDF for in another window

Editorials October 16 2023

Breast Cancer Outcome: What Have We Achieved

Volker Möbus; Marcus Schmidt

Breast Care (2023) https://doi.org/10.1159/000534589

View articletitled, Breast Cancer Outcome: What Have We Achieved

Open the PDF for in another window

Research Articles October 5 2023

Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study

Nadia Harbeck; Denise Wrobel; Matthias Zaiss; Jürgen Terhaag; Dagmar Guth; Andrea Distelrath; Mark-Oliver Zahn; Rachel Würstlein; Andreas Lorenz; Rupert Bartsch; Urs Breitenstein; Michael Schwitter; Marija Balic; Christian Jackisch; Volkmar Müller; Gabriel Rinnerthaler; Marcus Schmidt; Khalil Zaman; Timo Schinköthe; Anna Resch; Roberta Valenti; Diana Lueftner

Breast Care (2023) https://doi.org/10.1159/000533657

Abstract

View articletitled, Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study

Open the PDF for in another window

Case Reports September 30 2023

Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report about a Male Patient with Pectoral Implants

Kerstin Riecke; Lisa Steinhilper; Charlotte Von Bülow; Dorothee Schwarz; Eike Burandt; Jana Käthe Striefler; Volkmar Müller; Barbara Schmalfeldt; Isabell Witzel

Breast Care (2023) https://doi.org/10.1159/000534367

Abstract

View articletitled, Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report about a Male Patient with Pectoral Implants

Open the PDF for in another window

Discussions September 26 2023

Insights from ASCO 2023

Andreas Hartkopf; Wolfgang Janni; Maggie Banys-Paluchowski; Francois-Clement Bidard; Christoph Thomssen

Breast Care (2023) https://doi.org/10.1159/000533788

View articletitled, Insights from ASCO 2023

Open the PDF for in another window

Research Articles September 20 2023

Reimbursement in the Context of Precision Oncology Approaches in Metastatic Breast Cancer: Challenges and Experiences

Constantin Pixberg; Markus Schulze; Lars Buschhorn; Jan Philip Suppelna; Andreas Mock; Mario Hlevnjak; Sabine Heublein; Eva Schumacher-Wulf; Andreas Schneeweiss

Breast Care (2023) https://doi.org/10.1159/000533902

Abstract

View articletitled, Reimbursement in the Context of Precision Oncology Approaches in Metastatic Breast Cancer: Challenges and Experiences

Open the PDF for in another window

Review Articles September 19 2023

Endocrine Therapy: From Ovarian Ablation to Individualized Therapy and Signal Inhibition

Christian Jackisch; Athanasios Argyriadis

Breast Care (2023) https://doi.org/10.1159/000534154

Abstract

View articletitled, Endocrine Therapy: From Ovarian Ablation to Individualized Therapy and Signal Inhibition

Open the PDF for in another window

Research Articles September 16 2023

Strict versus Liberal Use of Sentinel Node Biopsy in Breast Cancer Surgery: Any Clinical Outcome Differences? A 20-Year Clinical Experience

Israel Barco; Marc García-Font; Antonio García-Fdez; Manel Fraile; Elena Vallejo; MCarmen Vidal; Sonia González; Clarisa González; Claudia Beatriz Mitru; Oriol Porta; Carolina Chabrera Sanz

Breast Care (2023) https://doi.org/10.1159/000533731

Abstract

View articletitled, Strict versus Liberal Use of Sentinel Node Biopsy in Breast Cancer Surgery: Any Clinical Outcome Differences? A 20-Year Clinical Experience

Open the PDF for in another window

Research Articles September 14 2023

Moderate Intensity Exercise Reduces Side Effects of Cancer Therapy and Maintains Cardiorespiratory Fitness in Male Breast Cancer Patients: Findings from the BRECA Male Crossover Study

Eva B. Schultz; Damir Zubac; Wilhelm Bloch; Hansjörg Baurecht; Jana Rickert; Freerk T. Baumann

Breast Care (2023) https://doi.org/10.1159/000534090

Abstract

View articletitled, Moderate Intensity Exercise Reduces Side Effects of Cancer Therapy and Maintains Cardiorespiratory Fitness in Male Breast Cancer Patients: Findings from the BRECA Male Crossover Study

Open the PDF for in another window

Review Articles September 13 2023

Locoregional Therapy: From Mastectomy to Reconstruction, Targeted Surgery, and Ultra-Hypofractionated Radiotherapy

Maggie Banys-Paluchowski; Steffi Hartmann; Nina Ditsch; Natalia Krawczyk; Thorsten Kühn; Jana de Boniface; Joanna Banys-Kotomska; Achim Rody; David Krug

Breast Care (2023) https://doi.org/10.1159/000533748

Abstract

View articletitled, Locoregional Therapy: From Mastectomy to Reconstruction, Targeted Surgery, and Ultra-Hypofractionated Radiotherapy

Open the PDF for in another window

Research Articles September 7 2023

Long-Term Follow-Up of High-Risk Breast Lesions at Vacuum-Assisted Biopsy without Subsequent Surgical Resection

Constanze Elfgen; Zsuzsanna Varga; Katrin Breitling; Eliane Pauli; Daniela Schwegler-Guggemos; Gert Kampmann; Rahel A. Kubik-Huch; Cornelia Leo; Domenico Lepori; Martin Sonnenschein; Christoph Tausch; Simone Schrading

Breast Care (2023) https://doi.org/10.1159/000533673

Abstract

View articletitled, Long-Term Follow-Up of High-Risk Breast Lesions at Vacuum-Assisted Biopsy without Subsequent Surgical Resection

Open the PDF for in another window

Research Articles August 17 2023

The Ongoing Necessity of Sentinel Lymph Node Biopsy for cT1–2N0 Breast Cancer Patients

Wenjun Jia; Xiao Chen; Xinyu Wang; Jianzhong Zhang; Tong Tang; Jianing Shi

Breast Care (2023) https://doi.org/10.1159/000532081

Abstract

View articletitled, The Ongoing Necessity of Sentinel Lymph Node Biopsy for cT1–2N0 Breast Cancer Patients

Open the PDF for in another window

Review Articles August 14 2023

Primary Prevention and Early Detection of Hereditary Breast Cancer

Dorothee Speiser; Ulrich Bick

Breast Care (2023) https://doi.org/10.1159/000533391

Abstract

View articletitled, Primary Prevention and Early Detection of Hereditary Breast Cancer

Open the PDF for in another window

Research Articles July 19 2023

Intention to Undergo Clinical Breast Examination and Its Associated Factors among Women Attending Rural Primary Healthcare Facilities in South Central Ethiopia

Bezawit Ketema; Mirgissa Kaba; Sarah Negash; Adamu Addissie; Eva Johanna Kantelhardt

Breast Care (2023) https://doi.org/10.1159/000531944

Abstract

View articletitled, Intention to Undergo Clinical Breast Examination and Its Associated Factors among Women Attending Rural Primary Healthcare Facilities in South Central Ethiopia

Open the PDF for in another window

Review Articles April 25 2023

Which Patients Need Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of Endocrine Response

Marcus Schmidt

Breast Care (2023) https://doi.org/10.1159/000530818

Abstract

View articletitled, Which Patients Need Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of Endocrine Response

Open the PDF for in another window

Early View

Research Articles December 5 2023

Budget Impact of the Oncotype DX Breast Recurrence Score® Test in Patients with Early Primary Hormone-Receptor-Positive, HER2-Negative, Node-Positive (pN1) Breast Cancer in Germany

Michael Patrick Lux; Christof Minartz; Harald Müller-Huesmann; Marianar Felicia Sandor; Sabine Radeck-Knorre; Aljoscha Neubauer

Breast Care (2023) https://doi.org/10.1159/000534096

Abstract

View articletitled, Budget Impact of the Oncotype DX Breast Recurrence Score® Test in Patients with Early Primary Hormone-Receptor-Positive, HER2-Negative, Node-Positive (pN1) Breast Cancer in Germany

Open the PDF for in another window

Latest
Most Read
Most Cited

Budget Impact of the Oncotype DX Breast Recurrence Score® Test in Patients with Early Primary Hormone-Receptor-Positive, HER2-Negative, Node-Positive (pN1) Breast Cancer in Germany

PharmaNews

Acknowledgement to Reviewers

The Factors Influencing Shoulder Mobility Disorders in Patients after Radical Breast Cancer Surgery: A Cross-Sectional Study

Online First / Early View

Online First

PharmaNews

Acknowledgement to Reviewers

The Factors Influencing Shoulder Mobility Disorders in Patients after Radical Breast Cancer Surgery: A Cross-Sectional Study

Erratum - Clinicopathologic Features and Pathogens of Granulomatous Lobular Mastitis

HER2+ Early Breast Cancer: From Escalation via Targeted and Post-Neoadjuvant Treatment to De-Escalation

Use of the Gene Expression Test Prosigna^® in Premenopausal Patients with HR+, HER2− Early Breast Cancer: Correlation of the Results with the Proliferation Marker Ki-67

Breast Cancer Outcome: What Have We Achieved

Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study

Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report about a Male Patient with Pectoral Implants

Insights from ASCO 2023

Reimbursement in the Context of Precision Oncology Approaches in Metastatic Breast Cancer: Challenges and Experiences

Endocrine Therapy: From Ovarian Ablation to Individualized Therapy and Signal Inhibition

Strict versus Liberal Use of Sentinel Node Biopsy in Breast Cancer Surgery: Any Clinical Outcome Differences? A 20-Year Clinical Experience

Moderate Intensity Exercise Reduces Side Effects of Cancer Therapy and Maintains Cardiorespiratory Fitness in Male Breast Cancer Patients: Findings from the BRECA Male Crossover Study

Locoregional Therapy: From Mastectomy to Reconstruction, Targeted Surgery, and Ultra-Hypofractionated Radiotherapy

Long-Term Follow-Up of High-Risk Breast Lesions at Vacuum-Assisted Biopsy without Subsequent Surgical Resection

The Ongoing Necessity of Sentinel Lymph Node Biopsy for cT1–2N0 Breast Cancer Patients

Primary Prevention and Early Detection of Hereditary Breast Cancer

Intention to Undergo Clinical Breast Examination and Its Associated Factors among Women Attending Rural Primary Healthcare Facilities in South Central Ethiopia

Which Patients Need Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of Endocrine Response

Early View

Budget Impact of the Oncotype DX Breast Recurrence Score® Test in Patients with Early Primary Hormone-Receptor-Positive, HER2-Negative, Node-Positive (pN1) Breast Cancer in Germany

INFORMATION

ABOUT US

SERVICES FOR

Karger International

Online First / Early View

Online First

Early View

This Feature Is Available To Subscribers Only